Antitrust agencies recognize the need for collaboration during COVID-19 emergency
The Department of Justice and Federal Trade Commission today announced expedited procedures for reviewing the antitrust impact of joint efforts among competitors related to the novel coronavirus. The agencies specifically noted that “health care facilities may need to work together in providing resources and services to communities without access to personal protective equipment, medical supplies, or health care.”
To the extent that there is a need for guidance, the agencies said they will work to resolve all COVID-19-related requests addressing public health and safety within seven calendar days of receiving all needed information
Related News Articles
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…